CHAPULMI

Welcome to the Brand page for “CHAPULMI”, which is offered here for Pharmaceutical preparations for the treatment of sarcoidosis, interstitial lung disease, pulmonary fibrosis, and idiopathic pulmonary fibrosis; pharmaceutical preparations for the treatment of pulmonary hypertension, pulmonary arterial hypertension (pah), pulmonary hypertension associated with lung disease, pulmonary hypertension associated with interstitial lung disease (ph-ild), pulmonary hypertension associated with chronic obstructive pulmonary disease, portopulmonary hypertension, pulmonary hypertension associated with sleep-related breathing disorders, pulmonary hypertension associated with chronic thrombotic and embolic disease, and pulmonary hypertension secondary to hematologic, metabolic, renal, granulomatous, or fibrotic disorders;.

Its status is currently believed to be active. Its class is unavailable. “CHAPULMI” is believed to be currently owned by “INSMED INCORPORATED”.